LONDON, June 6, 2012 /PRNewswire/ --Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, announces its TRUCLEAR 5.0 System, the smallest hysteroscopic morcellator system(1) to ...
ANDOVER, Mass., April 6, 2011 /PRNewswire/ -- Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division today announced that its TRUCLEAR™ System, an operative hysteroscopy device for the removal of ...
ANDOVER, Mass., Nov. 17 Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hysteroscopy device, which is now widely available in the ...
ANDOVER, Mass., Nov. 17 /PRNewswire-FirstCall/ -- Smith & Nephew's Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hysteroscopy ...
Unlike other intra uterine abnormality treatment options that use a high-frequency electric current, the TruClear system uses a simple mechanical approach to remove intrauterine tissue. Therefore, ...
Mumbai (Maharashtra) [India], November 2 (ANI/BusinessWire India): India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE:MDT), today announced the launch of the TruClear™ ...
Medtronic expanded its minimally invasive therapy portfolio on Wednesday with a deal to buy Smith & Nephew’s gynecology business for $350 million. London-based Smith & Nephew’s gynecology portfolio ...
On May 19, 2016, Medtronic (MDT) announced the acquisition of Smith & Nephew’s gynecology business for $350 million. It includes a minimally invasive surgical solution called the Truclear System. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback